187 related articles for article (PubMed ID: 36340967)
1. Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study.
Wang D; Wang H; Wu S; Yang X; Xu J
Int J Clin Pract; 2022; 2022():6725225. PubMed ID: 36340967
[TBL] [Abstract][Full Text] [Related]
2. Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema.
Mori Y; Murakami T; Suzuma K; Ishihara K; Yoshitake S; Fujimoto M; Dodo Y; Yoshitake T; Miwa Y; Tsujikawa A
PLoS One; 2017; 12(4):e0175809. PubMed ID: 28407012
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
[TBL] [Abstract][Full Text] [Related]
5. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone implant as an adjuvant therapy to ranibizumab loading dose in persistent diabetic macular edema.
Cakir A; Erden B; Bolukbasi S; Bayat AH; Ozturan SG; Elcioglu MN
Int Ophthalmol; 2019 Oct; 39(10):2179-2185. PubMed ID: 30470985
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
Okamoto M; Yamashita M; Ogata N
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
10. Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.
Ercalik NY; Yenerel NM; Imamoglu S; Kumral ET; Vural ET
J Ocul Pharmacol Ther; 2016 May; 32(4):225-9. PubMed ID: 27092435
[TBL] [Abstract][Full Text] [Related]
11. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
Wang XN; Cai X; He S; Zhang X; Wu Q
Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
[TBL] [Abstract][Full Text] [Related]
12. Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema.
Ercalik NY; Imamoglu S; Turkseven Kumral E; Yenerel NM; Bardak H; Bardak Y
Cutan Ocul Toxicol; 2018 Dec; 37(4):324-327. PubMed ID: 29619858
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of retinal inflammatory biomarkers after intravitreal steroid implant and Ranibizumab injection in diabetic macular edema.
Muftuoglu IK; Tokuc EO; Sümer F; Karabas VL
Eur J Ophthalmol; 2022 May; 32(3):1627-1635. PubMed ID: 34219488
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.
Sato S; Shinoda H; Nagai N; Suzuki M; Uchida A; Kurihara T; Kamoshita M; Tomita Y; Iyama C; Minami S; Yuki K; Tsubota K; Ozawa Y
Medicine (Baltimore); 2017 Apr; 96(16):e6459. PubMed ID: 28422835
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting the treatment frequency of ranibizumab injections during the second year in diabetic macular edema.
Nishikawa K; Murakami T; Ishihara K; Dodo Y; Terada N; Morino K; Tsujikawa A
Jpn J Ophthalmol; 2022 May; 66(3):296-304. PubMed ID: 35438397
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
Xu Y; Rong A; Xu W; Niu Y; Wang Z
BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
[No Abstract] [Full Text] [Related]
18. A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment.
Kaldırım H; Yazgan S; Kırgız A; Atalay K; Savur F
Curr Eye Res; 2019 Sep; 44(9):987-993. PubMed ID: 30983426
[No Abstract] [Full Text] [Related]
19. Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.
Fu Y; Wang P; Meng X; Du Z; Wang D
Doc Ophthalmol; 2017 Dec; 135(3):165-173. PubMed ID: 28756595
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
